- Home
- ARWR vs LGND Comparison
ARWR vs LGND Comparison
Compare ARWR & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- LGND
- Stock Information
- Founded
- ARWR 2003
- LGND 1987
- Country
- ARWR United States
- LGND United States
- Employees
- ARWR N/A
- LGND N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ARWR Health Care
- LGND Health Care
- Exchange
- ARWR Nasdaq
- LGND Nasdaq
- Market Cap
- ARWR 2.5B
- LGND 2.0B
- IPO Year
- ARWR 1993
- LGND 1992
- Fundamental
- Price
- ARWR $18.57
- LGND $111.71
- Analyst Decision
- ARWR Buy
- LGND Strong Buy
- Analyst Count
- ARWR 11
- LGND 6
- Target Price
- ARWR $45.33
- LGND $144.83
- AVG Volume (30 Days)
- ARWR 997.3K
- LGND 142.9K
- Earning Date
- ARWR 11-26-2024
- LGND 11-07-2024
- Dividend Yield
- ARWR N/A
- LGND N/A
- EPS Growth
- ARWR N/A
- LGND 160.46
- EPS
- ARWR N/A
- LGND 2.47
- Revenue
- ARWR $19,648,000.00
- LGND $152,422,000.00
- Revenue This Year
- ARWR N/A
- LGND $23.19
- Revenue Next Year
- ARWR $100.95
- LGND $15.08
- P/E Ratio
- ARWR N/A
- LGND $45.20
- Revenue Growth
- ARWR N/A
- LGND N/A
- 52 Week Low
- ARWR $17.05
- LGND $57.00
- 52 Week High
- ARWR $39.83
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ARWR 35.87
- LGND 48.80
- Support Level
- ARWR $21.20
- LGND $119.69
- Resistance Level
- ARWR $22.03
- LGND $125.76
- Average True Range (ATR)
- ARWR 0.87
- LGND 5.73
- MACD
- ARWR -0.04
- LGND -0.30
- Stochastic Oscillator
- ARWR 0.76
- LGND 25.51
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.